New drug combo tested to tame deadly prostate cancer
NCT ID NCT03263650
Summary
This study is testing if adding the drug olaparib after standard chemotherapy helps control a fast-growing, hard-to-treat form of prostate cancer. About 96 men with advanced, aggressive prostate cancer that has spread will receive chemotherapy, then some will receive olaparib pills while others are observed. The main goal is to see if olaparib keeps the cancer from growing longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.